Literature DB >> 19665062

Modular peptides promote human mesenchymal stem cell differentiation on biomaterial surfaces.

Jae Sam Lee1, Jae Sung Lee, William L Murphy.   

Abstract

Molecular design strategies in biomedical applications often involve creating modular "fusion" proteins, in which distinct domains within a single molecule can perform multiple functions. We have synthesized a new class of modular peptides that include a biologically active sequence derived from the growth factor BMP-2 and a series of hydroxyapatite-binding sequences inspired by the N-terminal alpha-helix of osteocalcin. These modular peptides can bind in a sequence-dependent manner to the surface of "bone-like" hydroxyapatite coatings, which are nucleated and grown on a biodegradable polymer surface via a biomimetic process. The BMP-2-derived sequence of the modular peptides is biologically active, as measured by its ability to promote osteogenic differentiation of human mesenchymal stem cells. Our study indicates that the modular peptides described here are multifunctional, and the characteristics of this approach suggest that it can potentially be applied to a range of biomaterials for regenerative medicine applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665062      PMCID: PMC2787789          DOI: 10.1016/j.actbio.2009.08.003

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  37 in total

1.  Effects of a bone-like mineral film on phenotype of adult human mesenchymal stem cells in vitro.

Authors:  William L Murphy; Susan Hsiong; Thomas P Richardson; Craig A Simmons; David J Mooney
Journal:  Biomaterials       Date:  2005-01       Impact factor: 12.479

2.  Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins.

Authors:  G K Hunter; P V Hauschka; A R Poole; L C Rosenberg; H A Goldberg
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

3.  Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro.

Authors:  D A Puleo
Journal:  J Cell Physiol       Date:  1997-10       Impact factor: 6.384

4.  Increased bone formation in osteocalcin-deficient mice.

Authors:  P Ducy; C Desbois; B Boyce; G Pinero; B Story; C Dunstan; E Smith; J Bonadio; S Goldstein; C Gundberg; A Bradley; G Karsenty
Journal:  Nature       Date:  1996-08-01       Impact factor: 49.962

5.  Unusually stable helix formation in short alanine-based peptides.

Authors:  S Marqusee; V H Robbins; R L Baldwin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

6.  A method for decarboxylation of gamma-carboxyglutamic acid in proteins. Properties of the decarboxylated gamma-carboxyglutamic acid protein from calf bone.

Authors:  J W Poser; P A Price
Journal:  J Biol Chem       Date:  1979-01-25       Impact factor: 5.157

7.  Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2.

Authors:  F Lecanda; L V Avioli; S L Cheng
Journal:  J Cell Biochem       Date:  1997-12-01       Impact factor: 4.429

8.  Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin.

Authors:  A L Boskey; S Gadaleta; C Gundberg; S B Doty; P Ducy; G Karsenty
Journal:  Bone       Date:  1998-09       Impact factor: 4.398

Review 9.  Mesenchymal stem cells.

Authors:  Brenton Short; Nathalie Brouard; Teresa Occhiodoro-Scott; Anand Ramakrishnan; Paul J Simmons
Journal:  Arch Med Res       Date:  2003 Nov-Dec       Impact factor: 2.235

10.  An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction.

Authors:  Carl A Gregory; W Grady Gunn; Alexandra Peister; Darwin J Prockop
Journal:  Anal Biochem       Date:  2004-06-01       Impact factor: 3.365

View more
  31 in total

1.  Comparing variable-length polyglutamate domains to anchor an osteoinductive collagen-mimetic peptide to diverse bone grafting materials.

Authors:  Jennifer L Bain; Bonnie K Culpepper; Michael S Reddy; Susan L Bellis
Journal:  Int J Oral Maxillofac Implants       Date:  2014 Nov-Dec       Impact factor: 2.804

2.  Controllable mineral coatings on PCL scaffolds as carriers for growth factor release.

Authors:  Darilis Suárez-González; Kara Barnhart; Francesco Migneco; Colleen Flanagan; Scott J Hollister; William L Murphy
Journal:  Biomaterials       Date:  2011-10-19       Impact factor: 12.479

3.  Enhancement of peptide coupling to hydroxyapatite and implant osseointegration through collagen mimetic peptide modified with a polyglutamate domain.

Authors:  Bonnie K Culpepper; Matthew C Phipps; Paul P Bonvallet; Susan L Bellis
Journal:  Biomaterials       Date:  2010-10-28       Impact factor: 12.479

4.  Osteogenic differentiation of 3D cultured mesenchymal stem cells induced by bioactive peptides.

Authors:  Vera Lukasova; Matej Buzgo; Vera Sovkova; Jana Dankova; Michala Rampichova; Evzen Amler
Journal:  Cell Prolif       Date:  2017-08       Impact factor: 6.831

5.  Stable biofunctionalization of hydroxyapatite (HA) surfaces by HA-binding/osteogenic modular peptides for inducing osteogenic differentiation of mesenchymal stem cells.

Authors:  Alessandro Polini; Jianglin Wang; Hao Bai; Ye Zhu; Antoni P Tomsia; Chuanbin Mao
Journal:  Biomater Sci       Date:  2014       Impact factor: 6.843

6.  Enhancement of the Regenerative Potential of Anorganic Bovine Bone Graft Utilizing a Polyglutamate-Modified BMP2 Peptide with Improved Binding to Calcium-Containing Materials.

Authors:  Jennifer L Bain; Paul P Bonvallet; Ramzi V Abou-Arraj; Peter Schupbach; Michael S Reddy; Susan L Bellis
Journal:  Tissue Eng Part A       Date:  2015-09       Impact factor: 3.845

7.  Detection of hydroxyapatite in calcified cardiovascular tissues.

Authors:  Jae Sam Lee; Joel D Morrisett; Ching-Hsuan Tung
Journal:  Atherosclerosis       Date:  2012-07-24       Impact factor: 5.162

Review 8.  Scaffold translation: barriers between concept and clinic.

Authors:  Scott J Hollister; William L Murphy
Journal:  Tissue Eng Part B Rev       Date:  2011-09-21       Impact factor: 6.389

9.  In vivo imaging of bone using a deep-red fluorescent molecular probe bearing multiple iminodiacetate groups.

Authors:  Kara M Harmatys; Erin L Cole; Bradley D Smith
Journal:  Mol Pharm       Date:  2013-10-22       Impact factor: 4.939

Review 10.  Tissue engineered bone mimetics to study bone disorders ex vivo: Role of bioinspired materials.

Authors:  Yuru Vernon Shih; Shyni Varghese
Journal:  Biomaterials       Date:  2018-06-06       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.